| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Idera Pharmaceuticals Inc (F: HXXB)
HXXB Technical Analysis
5
| As on 17th Mar 2023 HXXB STOCK Price closed @ 3.56 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.52 & Strong Buy for SHORT-TERM with Stoploss of 0.74 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HXXBSTOCK Price
| Open | 3.90 | Change | Price | % |
| High | 4.04 | 1 Day | -0.36 | -9.18 |
| Low | 3.56 | 1 Week | -0.60 | -14.42 |
| Close | 3.56 | 1 Month | -1.65 | -31.67 |
| Volume | N/A | 1 Year | 2.69 | 309.20 |
| 52 Week High 5.36 | 52 Week Low 0.16 | ||||
F Germany Most Active Stocks
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| IMU | 0.10 | -99.65% |
| ENB | 47.60 | -0.92% |
| TEF | 3.84 | -0.52% |
| TEF | 3.84 | -0.52% |
| WHL | 5150.00 | -0.44% |
| WDI | 0.05 | -37.50% |
F Germany Top Gainers Stocks
F Germany Top Losers Stocks
| HXXB Daily Charts |
HXXB Intraday Charts |
Whats New @ Bazaartrend |
HXXB Free Analysis |
|
|
HXXB Important Levels Intraday
| RESISTANCE | 4.48 |
| RESISTANCE | 4.19 |
| RESISTANCE | 4.00 |
| RESISTANCE | 3.82 |
| SUPPORT | 3.30 |
| SUPPORT | 3.12 |
| SUPPORT | 2.93 |
| SUPPORT | 2.64 |
HXXB Forecast April 2025
| 4th UP Forecast | 4.04 |
| 3rd UP Forecast | 3.89 |
| 2nd UP Forecast | 3.79 |
| 1st UP Forecast | 3.7 |
| 1st DOWN Forecast | 3.42 |
| 2nd DOWN Forecast | 3.33 |
| 3rd DOWN Forecast | 3.23 |
| 4th DOWN Forecast | 3.08 |
HXXB Weekly Forecast
| 4th UP Forecast | 3.73 |
| 3rd UP Forecast | 3.68 |
| 2nd UP Forecast | 3.64 |
| 1st UP Forecast | 3.61 |
| 1st DOWN Forecast | 3.51 |
| 2nd DOWN Forecast | 3.48 |
| 3rd DOWN Forecast | 3.44 |
| 4th DOWN Forecast | 3.39 |
HXXB Forecast2025
| 4th UP Forecast | 18.36 |
| 3rd UP Forecast | 13.61 |
| 2nd UP Forecast | 10.68 |
| 1st UP Forecast | 7.75 |
| 1st DOWN Forecast | -0.63 |
| 2nd DOWN Forecast | -3.56 |
| 3rd DOWN Forecast | -6.49 |
| 4th DOWN Forecast | -11.24 |
Idera Pharmaceuticals Inc ( F Germany Symbol : HXXB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HXXB Business Profile
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for oncology and rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, metastatic melanoma, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration and supply agreement with AbbVie Inc. and Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania. Address: 505 Eagleview Boulevard, Exton, PA, United States, 19341
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service